3. Soler-Catalu？a JJ, Cosío B, Izquierdo JL, et al.Consensus document on the overlap phenotype COPD-asthma in COPD.Arch Bronconeumol, 2012, 48:331-337.
[3]
4. 葛均波, 徐永健, 主编.内科学.北京:人民卫生出版社, 2013, 21-30.
[4]
5. Gibson PG, Simpson JL.The overlap syndrome of asthma and COPD:what are its features and how important is it? Thorax, 2009, 64:728-735.
[5]
6. Global strategy for asthma management and prevention 2014(revision). www.ginasthma.org.
[6]
7. Silva GE, Sherrill DL, Guerra S, et al.Asthma as a risk factor for COPD in a longitudinal study.Chest, 2004, 126:59-65.
[7]
11. Hizawa N.Pharmacogenetics of chronic obstructive pulmonary disease.Pharmacogenomics, 2013, 14:1215-1225.
[8]
1. GOLD Executive Committee.Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease(Revised 2014).[2014-05-08].http://www.goldcopd.com.
9. Vonk JM, Jongepier H, Panhuysen CI, et al.Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up.Thorax, 2003, 58:322-327.
[11]
10. Miravitlles M, Soler-Catalu？a JJ, Calle M, et al.A new approach to grading and treating COPD based on clinical phenotypes:summary of the Spanish COPD guidelines(GesEPOC).Prim Care Respir J, 2013, 22:117-121.
